Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Pemetrexed and Carboplatin in Non-Squamous NSCLC
NCT00906282Phase 2Completed
- Sponsor
- SCRI Development Innovations
- Start
- Jun 2009
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in non-small cell lung cancer (NSCLC), sponsored by SCRI Development Innovations. Started Jun 2009; status: completed.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00906282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00906282.